Not applicableStudy completedNCT03455283
What this trial is testing
Post-marketing Safety Study in Participants of All Pathologies Who Receive Gadolinium-Based Contrast Agents (GBCAs) for Contrast-Enhanced Magnetic Resonance Imaging (MR) Examination
Who this might be right for
Magnetic Resonance Imaging (MRI)
GE Healthcare 2,118